Company Overview
Verve Therapeutics is a clinical-stage genetic medicines company founded in 2018 by Andrew Bellinger and Sekar Kathiresan, focused exclusively on using base editing to treat cardiovascular disease. The company is developing one-time treatments that permanently lower LDL cholesterol and triglycerides by editing genes in liver cells that regulate lipid metabolism, including PCSK9 and ANGPTL3. Verve's approach targets the root cause of common cardiovascular disease rather than requiring lifelong daily medication, with the goal of a single infusion delivering durable benefit. The lead program VERVE-101 targets PCSK9 in liver cells and has entered Phase 1b clinical trials, with early data showing substantial and durable LDL reductions in patients with heterozygous familial hypercholesterolemia. Verve is publicly traded on Nasdaq and has established partnerships with Vertex Pharmaceuticals to advance the cardiovascular base editing pipeline. The company represents a fundamentally new approach to preventing heart attacks and strokes at the genetic level.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Verve Therapeutics is an emerging player bringing innovative solutions to the Biotechnology market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Adobe Firefly
Adobe Firefly is Adobe's generative AI platform and suite of creative AI tools, launched in March 2023 as Adobe's flagship response to the generative AI revolution. Firefly was purpose-built to be com
80 Acres Farms
80 Acres Farms is a commercial-scale indoor vertical farming company that, following its merger with Soli Organic, operates the largest indoor farming network in North America. The company raised $115
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Compare Verve Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Verve Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Verve Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Verve Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →